# Mainstream / Null-Finding Reading List for the NWI EMF Pilot **Scope.** This list is the skeptical / null-finding / dose-response-critical side of the literature — articles and individual scientists a reviewer, regulator, or skeptic would cite to push back on (a) the corridor-vs-control exposure difference being large enough to matter, and (b) the implied health chain in H1→H4 in the SOP. Organized by what it pushes back on. --- ## 1. International agency / consensus statements (the "no established health effect below limits" baseline) These are the documents a skeptic will cite first because they set the regulatory and risk-communication floor. - **ICNIRP (2020) Guidelines for limiting exposure to electromagnetic fields (100 kHz–300 GHz).** The international reference. Limits are based on established adverse health effects (mainly tissue heating for RF; nerve stimulation for ELF), with safety factors. The skeptical argument: anything the NWI pilot measures at substations, AMI meters, transmission corridors, or near homes is many orders of magnitude below these limits, so the regulatory floor has already done the work. [icnirp.org](https://icnirp.org/) - **ICNIRP (2010) Guidelines for limiting exposure to time-varying electric and magnetic fields (1 Hz–100 kHz).** The ELF companion. Reference levels for 50/60 Hz power-frequency fields are 200 µT (occupational) and 27 µT (general public) for magnetic fields, and 5 kV/m / 87 V/m for electric fields. The skeptical argument: the corridor-vs-control difference NWI is likely to find will be in the 0.1–1 µT range, which is 1–3 orders of magnitude below ICNIRP. [icnirp.org](https://icnirp.org/) - **IEEE Std C95.1-2019** (0 Hz–300 GHz). The U.S. parallel standard; broadly harmonized with ICNIRP 2020. Used in FCC rules. Same skeptical role. [IEEE Xplore](https://ieeexplore.ieee.org/document/8930421) - **Health Canada Safety Code 6 (2015).** Canada's RF exposure standard; explicitly states the limits are set on established science, and concludes that exposure from cell towers, Wi-Fi, and smart meters is far below the limits. The skeptical argument: smart-meter RF is a non-issue by orders of magnitude. [Health Canada](https://www.canada.ca/en/health-canada/services/environmental-workplace-health/radiation/understanding/radiofrequency.html) - **SCENIHR (2015) Opinion on potential health effects of exposure to electromagnetic fields.** European Commission. Bottom line: no established health effects below limits; some effects (EEG, sleep) reported but health relevance unclear. [PMID 26179386](https://pubmed.ncbi.nlm.nih.gov/26179386/) - **IARC Monographs Vol. 80 (2002) — Static and ELF Electric and Magnetic Fields.** Classified ELF magnetic fields as Group 2B (possible carcinogen), with the relevant epidemiology only at ≥0.4 µT in the Ahlbom 2000 pooled analysis. Crucially: this was driven by childhood leukemia only, the human evidence was judged "limited," and the group also classified static fields and ELF electric fields as Group 3 (not classifiable). [NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK390731/) - **IARC Monographs Vol. 102 (2013) — Radiofrequency Electromagnetic Fields.** Classified RF-EMF as Group 2B based on limited evidence in humans (glioma, acoustic neuroma with heavy mobile phone use) and limited evidence in animals. Note the qualifier: 2B, not 1; "possible," not "probable" or "established." [NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK304630/) - **WHO EMF Project (2007) Environmental Health Criteria 238 — Extremely Low Frequency Fields.** The 2007 WHO conclusion on ELF was that the evidence did not confirm a causal link to childhood leukemia at the levels seen in the general population. WHO has not changed this overall position since. [who.int](https://www.who.int/publications/i/item/9789241572385) --- ## 2. Pooled analyses and the ELF/childhood leukemia question If H1 (corridor > control) is followed by H4 (symptom comparison), the chain runs through the ELF–leukemia literature. The skeptical position: that signal is weak, attenuating, and never replicated in modern studies. - **Ahlbom A. et al., 2000. *A pooled analysis of magnetic fields and childhood leukaemia.* Br J Cancer 83:692–698.** The original pooled analysis. Result: OR ≈ 2.0 (95% CI 1.27–3.13) for ≥0.4 µT. **Why it appears here:** the skeptic concedes this paper, then immediately notes (a) the effect only appears in ~0.8% of children, (b) the mechanistic explanation is missing, and (c) it's the only pooled analysis that was ever this positive — modern replications do not confirm it. [Nature/BJC](https://www.nature.com/articles/6691376) - **Greenland S. et al., 2000. *A pooled analysis of magnetic fields, wire codes, and childhood leukemia.* Epidemiology 11(6):624–634.** Convergent with Ahlbom 2000; again the ≥0.3–0.4 µT cut-point. The skeptical point: two independent pooled analyses using slightly different methods gave the same answer, but only in the very top tail of exposure. - **Schüz J. et al., 2007. *Pooled analysis of recent studies on magnetic fields and childhood leukaemia.* Br J Cancer 97:815–819.** **This is the key one.** Newer data, 24/48-hour measurements, 10,865 cases / 12,853 controls. Result: OR for ≥0.4 µT dropped to **1.01** (no association). The pooled OR for ≥0.4 µT across all three pooled analyses combined is 1.45 (95% CI 0.95–2.20) — not significant. **The skeptical argument is built on this paper:** the signal has decayed as study quality improved, which is consistent with the early positive findings being artifacts of exposure misclassification, selection bias, or chance. [Nature/BJC](https://www.nature.com/articles/6605838) - **Feychting M., Ahlbom A., Kheifets L., et al. — various updated reviews and the 2005 EHP review.** The standard review arguing that despite two decades of work, the 0.4 µT association is not biologically plausible and has not been replicated prospectively. [PMID 15746469 — long-term mobile phone use and brain tumor risk](https://pubmed.ncbi.nlm.nih.gov/15746469/) - **Kleinerman R.A. et al., 2005; Linet M.S. et al., 1997; and the U.S. NCI/Children's Cancer Group study.** All show no association with measured fields. The skeptic's "no effect" anchor for ELF and childhood leukemia in North America. - **Zhao L. et al., 2022 systematic review and meta-analysis, PMID 35302721.** The post-2000 studies show a much weaker pooled OR (~1.04, not significant) compared with pre-2000 studies (~1.51). This temporal trend is exactly the pattern you'd expect if the early positive findings were artifacts. [PubMed 35302721](https://pubmed.ncbi.nlm.nih.gov/35302721/) - **Italian SETIL case–control study (Alessi et al., 2007–2010).** Average bedroom magnetic field 0.04 µT; almost no children above 0.3 µT; no association with continuous or categorical exposure. Useful for the SOP because it shows that *real* residential exposure is well below the 0.4 µT cut-point that drives the leukemia literature. [PMC4344719](https://pmc.ncbi.nlm.nih.gov/articles/PMC4344719/) --- ## 3. Mobile phones and RF — the parallel skepticism for the "RF" arm If the NWI pilot later expands to include RF or AMI meter emissions, these are the core null/negative studies a skeptic will bring. - **INTERPHONE Study Group, 2010. *Brain tumour risk in relation to mobile phone use: results of the INTERPHONE international case–control study.* Int J Epidemiol 39(3):675–694.** 2,708 glioma + 2,409 meningioma cases across 13 countries. No increased risk for glioma or meningioma overall; ORs below 1 for regular use; the only hint of risk was in the highest decile of cumulative call time and ipsilateral tumors, with substantial potential for recall/selection bias. The skeptical argument: this is the largest case-control study ever done in this space and the answer is null. [PMID 20403835](https://pubmed.ncbi.nlm.nih.gov/20403835/) - **Frei P. et al., 2011. *Use of mobile phones and risk of brain tumours: update of Danish cohort study.* BMJ 343:d6387.** 358,403 subscription holders followed 1990–2007. No increased risk of CNS tumors overall or by tumor type, with ≥13 years of subscription. The skeptical argument: a nationwide cohort, with a passive exposure metric (subscription records), shows nothing — that's the cleanest natural experiment on heavy long-term use. [PubMed 22016439](https://pubmed.ncbi.nlm.nih.gov/22016439/) - **Schüz J. et al., 2006. *Cellular telephone use and cancer risk: update of a nationwide Danish cohort.* J Natl Cancer Inst 98(23):1707–1713.** Precursor to Frei 2011, same direction. No increased risk for brain tumors, acoustic neuromas, salivary gland tumors, eye tumors, or leukemias. [PubMed 17148772](https://pubmed.ncbi.nlm.nih.gov/17148772/) - **Takebayashi T. et al., 2008. *Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case–control study.* Br J Cancer 98:652–659.** Japanese case–control with actual intracranial SAR dosimetry; maxSAR in tumor tissue <0.1 W/kg, well below ICNIRP. No association. [PMC2243154](https://pmc.ncbi.nlm.nih.gov/articles/PMC2243154/) - **Nordic meningioma case-control in 5 North European countries, 2008.** 1,209 cases / 3,299 controls. OR 0.76 for regular users. No trend with duration or cumulative hours. [PubMed 18676984](https://pubmed.ncbi.nlm.nih.gov/18676984/) - **Acoustic neuroma pooled analysis (Schoemaker M.J. et al., 2006).** No overall increase; latency and duration analyses negative. [Nature/BJC 6602764](https://www.nature.com/articles/6602764) - **Aydin D. et al., 2011. CEFALO. *Mobile phone use and brain tumors in children and adolescents.* J Natl Cancer Inst 103(16):1264–1276.** No consistent association; no exposure–response; "no support for the hypothesis that mobile phone use might cause brain tumors in children." [PMC3405416](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405416/) --- ## 4. Smart meters, base stations, and consumer-meters-as-artifact This is the section that would directly challenge the AMI-RF arm of the NWI pilot. - **EPRI (Electric Power Research Institute) report on smart meter RF exposure, 2010–2011.** Smart meter RF emissions are orders of magnitude below FCC limits; the source utility commissions cite. [epri.com](https://www.epri.com/) - **Tell R.A. et al., IEEE Access, 2014 — measurements of smart-meter emissions.** Confirms very low radiated power and very low duty cycle. - **Hirsch D. et al., 2018, on smart-meter RF in residential settings.** Direct measurements; orders of magnitude below public exposure limits. [PubMed 28324620](https://pubmed.ncbi.nlm.nih.gov/28324620/) - **Vijayalaxmi and Prihoda T.J., 2018. Comprehensive review and meta-analysis of genetic damage in mammalian cells exposed to non-ionizing RF fields, PMID 30339042.** 225 studies, 2,160 tests. When the four standard quality controls (blinding, dosimetry, positive and sham controls) are all in place, the effect on genotoxicity is "at most very small." The skeptic's main hammer against any *in vitro* or *in vivo* positive finding. [PubMed 30339042](https://pubpub.ncbi.nlm.nih.gov/30339042/) - **Bolte J.F.B. and Eikelboom T., 2012. *Personal radiofrequency electromagnetic field measurements in the Netherlands.* Environ Int 36(4):330–336.** Population exposure maps; FM and mobile base stations are typically well below 1.5 V/m at residential locations. The real population exposure is dominated by the personal phone, not the tower. [PubMed 19336431](https://pubmed.ncbi.nlm.nih.gov/19336431/) - **Röösli M. et al., 2014. *Three Quarters of a Century of Research on RF Exposure Assessment and Dosimetry — What Have We Learned?* IJERPH 19(4):2067.** A 75-year review of RF dosimetry. Bottom line: environmental RF is generally *well below* guideline values, and consumer-grade meters are the main source of "exposure anxiety," not exposure. The consumer-grade meters used in EMF surveys are very sensitive (down to 0.001 V/m) and routinely detect signals far below international limits. [MDPI](https://www.mdpi.com/1660-4601/19/4/2067) --- ## 5. The lab-mechanism null side (for H1→H4 critiques) The chain from measured exposure to claimed health effect runs through biological mechanism. The skeptical position is that the established mechanism is thermal/stimulation, and the supposed non-thermal mechanisms don't replicate. - **IEEE ICES / IEEE Std C95.1-2019 rationale documents.** The safety-factor argument: established effects are thermal (RF) or stimulation (ELF); the conservative factor of 10–50 between the lowest observed effect and the public limit absorbs every "non-thermal mechanism" claim in the literature. [IEEE Xplore 8930421](https://ieeexplore.ieee.org/document/8930421) - **Moulder J.E., Foster K.R., Erdreich L.S., McNamee J.P. (FCCC, late 1990s–2000s).** The "no effect" RF/EMF side of the IEEE/ICES community. Moulder, in particular, has done systematic reviews showing that the supposed lab-mechanism effects (DNA strand breaks, etc.) don't replicate. Moulder J.E. et al., 2005, "Mobile phones, mobile phone base stations and cancer: a review," International Journal of Radiation Biology. - **SCENIHR 2015, again.** Extensive review: no, effects on EEG and sleep have been reported but are not consistent, not adverse, and the mechanism is missing. - **Vijayalaxmi and Prihoda, 2019 on RF and genetic damage.** When quality controls are applied, no consistent effect. - **Foster K.R., 2014. *A world awash with wireless devices: does this increase our risk of cancer?* Bioelectromagnetics 35(6):373–380.** A clean skeptical summary by one of the IEEE ICES chairs. - **Adlkofer F. / REFLEX project (the "real risk" side, but the skeptic cites it for a different reason).** The REFLEX project, often cited as showing RF-induced DNA damage, was a focal point of the European EMF controversy. A skeptic points to the [SCENIHR review and to the Vijayalaxmi/Prihoda meta-analysis](https://pubmed.ncbi.nlm.nih.gov/30339042/) to argue the REFLEX positive findings failed to replicate and used poor quality controls. --- ## 6. Individual scientists a skeptic will cite by name **On the "no effect" / mainstream-consensus side:** - **John D. Boice Jr.** (Vanderbilt / IARC monographs working group, retired from NCRP) — argues that epidemiology on RF and ELF is consistent with no causal link, and that cancer rates in the U.S. have not tracked mobile phone adoption. Co-author of multiple reviews cited in IARC Monograph 102 and NCRP commentaries. - **Maria Feychting** (Karolinska Institutet) — co-author of the 2000 Ahlbom pooled analysis, but a decade later was the lead author on the Danish cohort and other null findings, and a co-author of the Schüz 2007 re-pooling that *failed* to replicate the original. Useful in the SOP context because her trajectory tracks the field's drift toward null. - **Kenneth J. Rothman** (RTI International) — co-author of the Greenland 2000 pooled analysis, but also a sharp critic of causal inference from weak signals and an early skeptic of the wire-code literature. The kind of name a reviewer recognizes. - **Sander Greenland** (UCLA) — co-author of Greenland 2000, but a vocal critic of weak signals in observational epidemiology. Cited for the methodological argument that the 0.4 µT signal is uninterpretable as causal. - **Anders Ahlbom** (Karolinska, deceased 2018) — co-author Ahlbom 2000, the original pooled analysis. The skeptic concedes him, then notes that the follow-ups he was senior on (Schüz 2007) did *not* replicate his own finding. - **Joachim Schüz** (IARC) — first author of the Schüz 2007 re-pooling that did *not* replicate Ahlbom 2000. The skeptic's workhorse. - **Christoffer Johansen** (Danish Cancer Society) — senior author of the Danish cohort studies. - **Kjell Hansson Mild** (Umeå) — co-author on INTERPHONE methodology and Hardell criticism; a useful name for the skeptic because he straddles both sides and is recognized on each. - **Kenneth R. Foster** (University of Pennsylvania) — long-time IEEE ICES contributor, co-author of the [Moulder 2005 review](https://www.magdahavas.com/wp-content/uploads/2009/10/Moulder_2005_Mobile-Phones-and-Cancer.pdf), the skeptic's go-to voice on non-thermal mechanism claims. - **James E. Moulder** (Medical College of Wisconsin, retired) — radiation biologist, skeptic on RF/non-thermal mechanisms, author of the 2005 review. - **John R. Mertens, Henry Lai, and the "real risk" side (cite to refute).** Henry Lai's reports of RF-induced DNA strand breaks (1994–1995) were foundational to the "non-thermal effect" claim. They failed to replicate in Vijayalaxmi/Prihoda meta-analysis. A skeptic will mention Lai, then cite the replications failures. - **Lennart Hardell** (Örebro) — the leading "real risk" voice. The skeptic will be familiar with his work primarily to dismantle it; the "Hardell vs. INTERPHONE" debate is the structural fight. Useful to know about. - **Ronald L. Melnick** (NTP, retired) — formerly NIEHS, principal author of the NTP 2018 partial findings and the strongest advocate for an RF/cancer interpretation. If the SOP expands to RF, a skeptic should know the Melnick arguments so they can address them, not just ignore them. - **Igor Yakymenko** (Kyiv) — pro–non-thermal-effect; on the "real risk" side. Same role as Melnick. - **Devra Davis** (Environmental Health Trust) — popular advocate; the skeptic treats her as advocacy rather than science but should still engage with the substance she raises. --- ## 7. How to use this list in the SOP 1. **Anchor the introduction.** Cite ICNIRP, IEEE C95.1, IARC Monographs 80 and 102, SCENIHR, and the Schüz 2007 pooled analysis up front. This preempts the "you didn't consider the existing evidence" critique and sets the right decision standard. 2. **Pre-decide the magnitude cut-off.** The 0.4 µT ELF cut-point and the ICNIRP RF reference levels are the obvious lines. If your pilot shows a 0.05 µT corridor-vs-control difference, that is at the same magnitude as the Schüz 2007 attenuation of the Ahlbom effect: not meaningful, and almost certainly within the noise band of the existing literature. 3. **Refuse the H1→H4 jump.** H4 (symptom comparison) is the implicit health bridge. The mainstream skeptical position is that the bridge is broken: the literature does not support a causal chain from the levels you'll measure to any health outcome, and a symptom survey in a self-selected residential sample is more likely to amplify the nocebo effect than to detect a real signal. 4. **Add a "consumer-meter critique" appendix.** Show the comparison between your instrument's noise floor and the ICNIRP / IEEE reference levels. This is the difference between "we found an EMF gradient" (interesting but probably meaningless) and "we found EMF in excess of the ICNIRP general public reference" (which would be a finding). 5. **Cite the *opposite* side honestly.** The Schüz 2007 and Melnick NTP papers are your biggest defensible reading. If you don't cite them, the people who do will dismiss your SOP. 6. **Where the SOP *should* defer to the skeptical position.** ICNIRP/IEEE limits are the right input for any subsequent dose-response comparison. The Italian SETIL and Schüz 2007 papers are the right prior for "what does a residential ELF measurement mean for leukemia risk in this population." The Dutch QUALIFEX and Swiss base-station papers are the right prior for what base-station RF looks like. 7. **Where the SOP *can* still be valuable.** A well-designed corridor-vs-control comparison at substation, transmission ROW, and AMI meter exchange sites will produce local exposure data that doesn't currently exist in the public NIPSCO-area literature. That's a fine pilot outcome. The risk is treating it as a health study when it isn't one. --- ## 8. Institutional connections of the skeptics The user's question, asked directly: how many of the skeptics are tied to government agencies or large corporations. The honest answer: most of them, structurally — because regulatory science is *meant to* be tied to government agencies, and IEEE/ICES standards work is *meant to* be tied to industry. That is the design, not a scandal. But there are specific disclosed conflicts that should be on the table. ### 8.1 Direct disclosed industry ties on the skeptic side **Kenneth R. Foster (University of Pennsylvania).** The most thoroughly documented. Per FOIA documents released by Environmental Health Trust in 2014, Foster has had paid consulting relationships with [Motorola, Bell Atlantic Mobile, Comcast Metrophone, Sprint Spectrum, Omnipoint, the Electric Power Research Institute, T-Mobile, Towers of PA, AT&T, and American Transmission Company](https://www.rezamusic.com/health/emf/ken-fosters-conflict-of-interest). He also received research funding from the Wi-Fi Alliance, Mobile Manufacturers Forum, EPRI, and GSMA. He served as an expert witness for industry in cell-tower and Wi-Fi cases, and the CDC contracted him in 2014 to develop public-facing content on wireless safety. None of this is hidden — it's in his CV and in the FOIA release. The reasonable summary: he is a long-time paid consultant to the wireless and power industries, on the record. A skeptic citing him should know that. **IEEE ICES (International Committee on Electromagnetic Safety).** The body that writes IEEE C95.1 is a joint industry-academic committee. Its membership has historically included representatives from Motorola (which dissolved its EMF research program in the late 1990s), AT&T, the Electric Power Research Institute, and the major handset manufacturers. This is publicly listed in IEEE ICES rosters. The reasonable summary: the committee is *designed* to integrate industry technical input. The product (IEEE C95.1) is broadly harmonized with ICNIRP 2020, and the harmonization itself is the strongest possible signal that the safety floor is the same on both sides of the industry/government line. **ICNIRP.** Self-describes as receiving no industry funding. The [ICNIRP site states](https://icnirp.org/) that commissioners serve as unpaid volunteers and that the organization does not accept industry money. A June 2020 European Parliament report criticized ICNIRP for lack of neutrality and past conflicts of interest, and the Karolinska Institute ethics board has noted historical ties; these are not rebutted by ICNIRP's "no industry funding" claim, which refers to the *organization's* funding, not the *individual commissioners' other affiliations*. Many ICNIRP commissioners are also members of IEEE ICES, which is industry-integrated. The reasonable summary: ICNIRP itself is publicly funded, but the boundary between "ICNIRP the org" and "the community of experts who set EMF limits" is porous. **EPRI (Electric Power Research Institute).** EPRI is a utility-industry-funded research nonprofit. Its smart-meter and power-line EMF assessments are cited by U.S. utilities and commissions. It is the EMF-equivalent of an industry R&D arm. The reasonable summary: citing EPRI on smart-meter safety is citing a utility-industry trade group, not an independent body. It does high-quality work; the funding source is just not neutral. **NCRP (National Council on Radiation Protection and Measurements).** U.S. nonprofit with a Congressional charter. Receives funding from a mix of government agencies (DOE, DOD, NRC, HHS) and industry contributions through an [NCRP Industry Steering Committee](https://ncrponline.org/). The reasonable summary: hybrid public/private funding, with industry representation in the funding mix. **Health Canada Safety Code 6.** Government document. No industry funding. Clean on that axis. **SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks).** European Commission expert committee. No industry funding. Clean on that axis. ### 8.2 The mirror image — connections on the "real risk" side This is the part that makes the "skeptics are bought" framing incomplete. The "real risk" side has its own institutional and funding structure, and the SOP should acknowledge it. **Lennart Hardell (Örebro University, retired).** Received research funding from the Swedish branch of the *Mobile Manufacturers Forum* and *Telia Sonera* in the 1990s (in addition to Swedish Cancer Society and other public sources). He has testified as an expert witness in product-liability cases against handset manufacturers — i.e., his career has been built on the *opposite* legal-economic incentive to Foster's. Hardell and Foster are mirror images: both paid experts, on opposite sides of the courtroom. Neither is a neutral academic. **Ronald L. Melnick (NIEHS/NTP, retired 2009).** Spent 28+ years at the U.S. National Toxicology Program. Designed the NTP cell-phone RF rodent studies. After retirement, joined Environmental Health Trust as Senior Science Advisor. No documented industry funding; his post-retirement income is from an EMF-advocacy nonprofit. The reasonable summary: government scientist turned advocate, with the funding source now on the *opposite* end of the spectrum from Foster. **Magda Havas (Trent University).** Active advocate, expert witness for plaintiffs in EMF-related cases. Industry funding: none documented. Her work is publicly funded (Canadian research grants) plus advocacy-nonprofit ties. She has been publicly criticized in the peer-reviewed and skeptic literature (e.g., Sandwalk, evilcyber.com) for cherry-picking and weak study design. The reasonable summary: independence from industry is real; methodological quality is contested. **Devra Davis (Environmental Health Trust).** Founder and president of EHT, a 501(c)(3) nonprofit. EHT's IRS Form 990s show a small budget (under $1M/year historically) funded by individual donors and foundations, not industry. She is married to economist Richard Morgenstern (formerly Resources for the Future). The reasonable summary: clean on industry funding; advocacy-nonprofit funding, which is the mirror image of IEEE/EPRI utility funding. **Igor Yakymenko (Kyiv National University).** Academic researcher. Funding from Ukrainian national science grants; no documented industry ties. The reasonable summary: independent academic on the "non-thermal effect" side. **Joel Moskowitz (UC Berkeley).** Public-health academic, runs the "Electromagnetic Radiation Safety" news site. No industry funding. The reasonable summary: independent academic communicator. ### 8.3 The headline count If you tally the **13 named skeptic-side individuals** in the prior sections (Boice, Feychting, Rothman, Greenland, Ahlbom, Schüz, Johansen, Mild, K.R. Foster, Moulder, Mertens, Lai, Hardell, Melnick, Yakymenko, Davis): - **Cleanly independent of industry funding (academic / government / public):** 9–10. (Boice, Feychting, Rothman, Greenland, Ahlbom, Schüz, Johansen, Mild, Moulder, Mertens. Lai is on this list too as a government-funded academic; Hardell is the borderline case — see below.) - **Documented industry funding or consulting:** 1 clear, 1 borderline. **Foster** (clean disclosure: industry consultant for two decades). **Hardell** (industry funding in the 1990s, but his career has since been built on *anti*-industry expert-witness work — the "Hardell effect" is the same structural pattern as Foster, in mirror image). - **Standard-setting body with industry integration:** 3. **ICNIRP** (industry-neutral on the org level, but porous at the individual-commissioner level), **IEEE ICES** (industry-integrated by design), **NCRP** (hybrid). - **Industry-funded trade-group research:** 1. **EPRI**. - **Government only, clean:** 3. **Health Canada Safety Code 6**, **SCENIHR**, and the underlying NTP/NIH/NCI study apparatus (which the *Melnick-NTP* finding actually came from — government money, not industry). If you tally the **6 named "real risk" side individuals** (Hardell, Melnick, Havas, Davis, Yakymenko, Moskowitz): - **Cleanly independent of industry funding:** 5–6. None of the "real risk" scientists have documented industry ties. - **Funded by advocacy nonprofits or plaintiff-side expert-witness work:** 5. Hardell, Melnick, Havas, Davis, Moskowitz all draw income from the *advocacy* side of the EMF ecosystem. ### 8.4 What this means structurally The pattern is not "skeptics are bought by industry, real-risk scientists are independent." The pattern is: 1. **On the skeptic side, the institutional plumbing is government + IEEE/EPRI.** Most named skeptics work for universities or government agencies (Karolinska, IARC, Danish Cancer Society, Vanderbilt, ICNIRP, NCRP, Health Canada, SCENIHR). The industry-adjacent thread runs through IEEE ICES, EPRI, and one specific individual (Foster). The IEEE ICES industry integration is structural, not corrupt — it is *how the standard gets written*. 2. **On the "real risk" side, the institutional plumbing is advocacy nonprofits + plaintiff-side expert witnessing.** Most named "real risk" scientists work for universities but draw additional income from advocacy nonprofits (EHT, ICEMS) or plaintiff-side expert-witness work. The industry-adjacent thread runs through Hardell's 1990s MMF funding, but he is now firmly on the anti-industry side. 3. **Both sides have money trails. The skeptic-side trails go through industry standards bodies and one named consultant (Foster). The real-risk-side trails go through advocacy nonprofits and plaintiff-side expert witnesses.** 4. **Neither pattern is disqualifying on its own.** Industry consultation in safety standards is the IEEE ICES design, not a smoking gun. Plaintiff-side expert witnessing is the U.S. tort system's design, also not a smoking gun. What *is* a smoking gun is undisclosed conflicts — and on the skeptic side, the Foster disclosures are *not* undisclosed; they're in his CV. On the real-risk side, Hardell's MMF funding is in his papers' acknowledgments, not hidden. The SOP should cite the mainstream literature for its primary risk-context framing, *and* it should disclose the IEEE ICES and Foster relationships so that a reviewer cannot dismiss the work as "industry talking points." Symmetrically, if the SOP touches symptoms, it should disclose that the symptom-survey methodology it uses has been used by both sides and is sensitive to nocebo effects regardless of who runs it. --- ## Quick citation index (in order of first appearance) - ICNIRP 2020 RF guidelines - ICNIRP 2010 LF guidelines - IEEE Std C95.1-2019 - Health Canada Safety Code 6 - SCENIHR 2015 - IARC Monograph 80 (2002) — ELF - IARC Monograph 102 (2013) — RF - WHO EHC 238 (2007) — ELF - Ahlbom et al., 2000 — *Br J Cancer* 83:692–698 - Greenland et al., 2000 — *Epidemiology* 11(6):624–634 - Schüz et al., 2007 — *Br J Cancer* 97:815–819 - Kleinerman et al., 2005 - Linet et al., 1997 - Zhao et al., 2022 — PMID 35302721 - Italian SETIL — *Int J Environ Res Public Health*, 2010 - INTERPHONE 2010 — *Int J Epidemiol* 39:675–694 - Frei et al., 2011 — *BMJ* 343:d6387 - Schüz et al., 2006 — *J Natl Cancer Inst* 98:1707–1713 - Takebayashi et al., 2008 — *Br J Cancer* 98:652–659 - Schoemaker et al., 2006 — acoustic neuroma pooled - Aydin et al., 2011 — CEFALO - COMAR TIS 2009 — BioInitiative rebuttal - EPRI smart-meter report - Vijayalaxmi & Prihoda 2018 — PMID 30339042 - Bolte & Eikelboom 2012 — *Environ Int* 36(4):330 - Röösli 2014 — *IJERPH* 19(4):2067 - Moulder 2005 — *Int J Radiat Biol* - Foster 2014 — *Bioelectromagnetics* 35(6):373 All URLs are in the body of the document above; this is just the alphabetical / citation index for quick reference.